Efficacy and Safety of Omalizumab for the Treatment of Severe or Poorly Controlled Allergic Diseases in Children: A Systematic Review and Meta-Analysis

OBJECTIVE: To evaluate the efficacy and safety of omalizumab in the treatment of severe or uncontrolled allergic diseases in children. METHODS: We conducted a systematic search of the PubMed, Embase, CENTRAL, and clinicaltrials.gov databases up to 23rd July 2021, with no language limitations. Random...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ling, Zhou, Pengxiang, Wang, Zhenhuan, Zhai, Suodi, Zhou, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965060/
https://www.ncbi.nlm.nih.gov/pubmed/35372142
http://dx.doi.org/10.3389/fped.2022.851177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8965060/
https://www.ncbi.nlm.nih.gov/pubmed/35372142
http://dx.doi.org/10.3389/fped.2022.851177

Ejemplares similares